Shenzhen New Industries Biomedical Engineering Co., Ltd.
300832
Pozycja w akcjach
#2881
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the... Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.
Cena akcji
$8.03
Kapitalizacja rynkowa
$6.31B
Zmiana (1 dzień)
1.07%
Zmiana (1 rok)
-8.04%
Kraj
CN
Handel Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Kategoria
Healthcare
EPS dla Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
EPS na dzień June 2026 TTM: $0.33
Według najnowszych raportów finansowych i ceny akcji firmy Shenzhen New Industries Biomedical Engineering Co., Ltd., obecny EPS (TTM) wynosi $0.33. Na koniec roku 2024 firma miała EPS w wysokości $0.32, wzrost w porównaniu do do EPS z roku 2023, który wynosił $0.30.
Historia EPS dla Shenzhen New Industries Biomedical Engineering Co., Ltd. od 2012 do 2026
EPS na koniec każdego roku
| Rok | EPS | Zmień |
|---|---|---|
| 2026 (TTM) | $0.33 | 12.55% |
| 2025 | $0.29 | -7.77% |
| 2024 | $0.32 | 7.58% |
| 2023 | $0.30 | 21.10% |
| 2022 | $0.25 | 25.58% |
| 2021 | $0.20 | 1.99% |
| 2020 | $0.19 | 21.08% |
| 2019 | $0.16 | 9.80% |
| 2018 | $0.14 | 23.20% |
| 2017 | $0.12 | 26.68% |
| 2016 | $0.09 | 66.43% |
| 2015 | $0.06 | -7.20% |
| 2014 | $0.06 | 72.54% |
| 2013 | $0.03 | 96.59% |
| 2012 | $0.02 | 0.00% |
EPS dla podobnych firm lub konkurentów
| Firma | EPS | Różnica w EPS | Kraj |
|---|---|---|---|
| $2.70 | 727.21% |
US
|
|
| $4.09 | 1,153.06% |
IE
|
|
| $9.73 | 2,881.00% |
US
|
|
| $2.48 | 659.80% |
US
|
|
| $2.22 | 581.25% |
DE
|
